Heart Test Laboratories
HSCS
4 hedge funds and large institutions have $80K invested in Heart Test Laboratories in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, 1 reducing their positions, and 3 closing their positions.
0% more funds holding
Funds holding: 4 → 4 (0)
0% more ownership
Funds ownership: 0.01% → 0.01% (+0%)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
4% less capital invested
Capital invested by funds: $83K → $80K (-$3K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AWM
AE Wealth Management
Topeka,
Kansas
|
+$42.7K |
| 2 |
OLVIG
Oliver Lagore Vanvalin Investment Group
Flint,
Michigan
|
+$42.7K |
| 3 |
Renaissance Technologies
New York
|
+$26.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$44K |
| 2 |
Jane Street
New York
|
-$28K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$4.27K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AWM
1
AE Wealth Management
Topeka,
Kansas
| $30K | +$42.7K | +250 | New |
|
|
OLVIG
2
Oliver Lagore Vanvalin Investment Group
Flint,
Michigan
| $30K | +$42.7K | +250 | New |
|
|
3
Renaissance Technologies
New York
| $18K | +$26.7K | +156 | New |
|
|
4
UBS Group
Zurich,
Switzerland
| $2K | -$4.27K | -25 | -58% |
|
|
5
Citadel Advisors
Miami,
Florida
| – | -$44K | -234 | Closed |
|
|
6
Jane Street
New York
| – | -$28K | -149 | Closed |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| – | -$3K | -17 | Closed |
|
HSCS Hedge Fund Activity: Q3 2022 in Review
4 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Heart Test Laboratories (HSCS) for Q3 2022, worth a combined $80K — down 3.6% from $83K a quarter earlier.
Fund positioning in HSCS was balanced in Q3 2022: 3 funds opened new positions, 3 closed out, 0 added to existing stakes and 1 trimmed.
The largest buyer was AE Wealth Management, opening a new position worth an estimated $42.7K. The largest seller was Citadel Advisors, exiting entirely with an estimated $44K sold.
- 4 institutional investors held Heart Test Laboratories (HSCS) as of Q3 2022, unchanged from Q2 2022.
- Funds reported $80K of Heart Test Laboratories stock for Q3 2022, down 3.6% quarter-over-quarter.
- 3 funds opened new Heart Test Laboratories positions in Q3 2022 and 3 closed out, a net change of 0 holders.
- The largest Heart Test Laboratories buyer in Q3 2022 was AE Wealth Management, an estimated $42.7K added.
- The largest Heart Test Laboratories seller in Q3 2022 was Citadel Advisors, an estimated $44K sold.
Based on aggregated 13F filings for Q3 2022.